CLASS II ONGOING Device recall · Reported 21 Apr 2021 · FDA Enforcement Report

cobas Liat Analyzer: respiratory virus panel nucleic acid recalled

Roche Molecular Systems is recalling cobas Liat Analyzer: respiratory virus panel nucleic acid assay system, distributed nationwide in the US. The recall was initiated on 25 Mar 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll serial ID numbers
Quantity recalledUS: 5,430 units ; OUS 1528 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1414-2021
FDA event ID
87622
Recalling firm
Roche Molecular Systems, Branchburg, NJ
Classification
Class II
Status
Ongoing
Recall initiated
25 Mar 2021
FDA classified
12 Apr 2021
Reported
21 Apr 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

25 Mar 2021Recall initiated by company
12 Apr 2021Classified by FDA+18 days
21 Apr 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

cobas Liat Analyzer: respiratory virus panel nucleic acid assay system Catalog Number: 07341920190

Where it was distributed

Nationwide WorldWide

Nationwide

Questions about this recall

Is cobas Liat Analyzer: respiratory virus panel nucleic acid assay system recalled?

Yes. Roche Molecular Systems recalled cobas Liat Analyzer: respiratory virus panel nucleic acid assay system on 25 Mar 2021. The recall is Class II and its status is Ongoing. Recall number Z-1414-2021.

Why was it recalled?

Invalid or false positive results for one or more targets (SARS-CoV-2/Influenza A/Influenza B) using the cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization on the cobas Liat analyzer, showed abnormal PCR growth curves

Which lots are affected?

All serial ID numbers

Where was it sold?

Nationwide WorldWide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Molecular Systems

All 42

Other CPAP & Ventilators recalls

All 552